Economy · World
GSK to invest $800 million in Pennsylvania biopharma hub
GlaxoSmithKline (GSK) plans to invest over $800 million to expand its biopharmaceutical hub in Pennsylvania, a move expected to create 300 jobs. The company's investment will focus on enhancing its biopharma capabilities within the state.
How outlets across the spectrum covered it
L 0 C 2 R 0
- Centre (2): Reuters, The Economic Times